The FMT National Registry, established by the AGA in partnership with other organizations, provides initial results on the safety and effectiveness of FMT for the management of Clostridioides difficile infections.
A team of investigators sought to determine the influence of infliximab on gut bacterial and fungal composition in patients with inflammatory bowel disease.
Investigators characterized the gut microbiota of children with celiac disease to collect data on the determinants of the microbiota likely to change in children following a gluten-free diet.
Investigators used a quasi-paired cohort strategy to study how the microbiome, specifically microbial detoxification, might contribute to the pathogenesis of autism spectrum disorder.
Researchers assessed whether the gut microbiome in ankylosing spondylitis and inflammatory bowel disease was different, and whether it correlated with disease activity.
Trio-SmartTM, a novel new breath test developed to measure hydrogen, methane, and hydrogen sulfide, is now available and can be ordered on the test’s website.
Investigators evaluated the safety and efficacy of Lactobacillus plantarum (LRCC5310), a probiotic organism, in children hospitalized with rotaviral gastroenteritis.
While the etiopathogenesis of diverticulitis is not completely understood, recent evidence suggests that chronic inflammation and alterations in the gut microbiome may be key factors in the development of diverticulitis.
Researchers compared integrated multidisciplinary clinical care vs gastroenterologist-only care with regard to symptoms, specific functional disorders, psychological state, quality of life, and cost of care for treating functional gastrointestinal disorders.
Researchers analyzed the relationship between an altered gut microbiome and complications of cirrhosis and survival and sought to determine its effect on disease progression and prognosis.
The FDA, CDC, and several gastroenterology societies have partnered to review ways to reduce duodenoscope-associated transmission of carbapenem-resistant Enterobacteriaceae.
Researchers conducted the first prospective study analyzing the efficacy offecal microbiota transplantation for patients with inflammatory bowel disease and C difficile infection.
In post-hoc analyses, researchers analyzed alcohol use data and whole-blood samples from 359 participants in the New Orleans Alcohol Use in HIV study to explore the association between intestinal leak, dysbiosis, and T cells.
This study assessed the contribution of the proximal small intestinal microbiota to stunting in an undernourished pediatric population who did not respond to nutritional intervention.
As the role of the gut microbiome in nonalcoholic fatty liver disease is explored, research has turned to fecal microbiota transplantation as a potential treatment option.
